Metastatic triple negative breast cancer: Optimizing treatment options, new and emerging targeted therapies

E-ISSN： 1743-7563|14|1|32-39

ISSN： 1743-7555

Source： ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol.14, Iss.1, 2018-02, pp. : 32-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Combination of Targeted Therapy with Chemotherapy Backbone Induces Response in a Treatment-Resistant Triple-Negative MCL1-Amplified Metastatic Breast Cancer Patient

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-02 ,pp. : 112-118

Karger

Access to resources Recommend Favorite

Is Capecitabine Efficacious in Triple Negative Metastatic Breast Cancer?

Oncology, Vol. 79, Iss. 5-6, 2011-03 ,pp. : 331-336

Karger

Access to resources Recommend Favorite

Optimizing Quality of Life in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: Treatment Options and Considerations

Oncology, Vol. 93, Iss. 3, 2017-06 ,pp. : 143-156

Karger

Access to resources Recommend Favorite

Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti‐HER2 targeted therapies

CANCER, Vol. 122, Iss. 17, 2016-09 ,pp. : 2654-2662

John Wiley & Sons Inc

Access to resources Recommend Favorite

Triple-negative breast cancer

By Bartsch Rupert

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 7-8, 2010-04 ,pp. : 174-181

Springer Publishing Company

Access to resources Recommend Favorite